Skip to main content
XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.600
-0.040 (-2.44%)
At close: Nov 13, 2026, 4:00 PM EST
1.560
-0.040 (-2.50%)
After-hours: Nov 13, 2026, 4:10 PM EST

XTL Biopharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.080.371.42.092.97
Trading Asset Securities
-0.770.611.633.16
Cash & Short-Term Investments
0.081.142.013.726.13
Cash Growth
-93.35%-43.02%-46.09%-39.27%1.41%
Accounts Receivable
-0.1---
Receivables
-0.1---
Prepaid Expenses
-0.050.030.070.09
Other Current Assets
0.090.050.010.010.02
Total Current Assets
0.171.342.053.816.24
Property, Plant & Equipment
-0.19--0
Goodwill
-3.19---
Other Intangible Assets
-3.820.380.380.38
Other Long-Term Assets
-0.01---
Total Assets
0.178.552.434.196.62

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.020.23000
Accrued Expenses
0.130.550.210.190.23
Short-Term Debt
-0.14---
Current Unearned Revenue
-0.02---
Other Current Liabilities
0.271.28---
Total Current Liabilities
0.422.210.210.190.23
Long-Term Deferred Tax Liabilities
-0.22---
Other Long-Term Liabilities
-0.69--1.05
Total Liabilities
0.423.120.210.191.29

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
25.1423.1414.1214.1214.12
Additional Paid-In Capital
140.22141.29146.33146.33146.33
Retained Earnings
-165.63-159.01-158.25-156.47-155.13
Comprehensive Income & Other
0.020.020.020.020.02
Shareholders' Equity
-0.255.442.2245.33
Total Liabilities & Equity
0.178.552.434.196.62

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-0.14---
Net Cash (Debt)
0.081.012.013.726.13
Net Cash Growth
-92.44%-49.90%-46.09%-39.27%1.41%
Net Cash Per Share
0.000.000.000.010.01
Filing Date Shares Outstanding
982.99881.39544.91544.91544.91
Total Common Shares Outstanding
946.24881.39544.91544.91544.91
Working Capital
-0.25-0.871.843.626.01
Book Value Per Share
-0.000.010.000.010.01
Tangible Book Value
-0.25-1.571.843.624.95
Tangible Book Value Per Share
-0.00-0.000.000.010.01
SEC Filings: 10-K · 10-Q